Therakos
Therakos LLC specializes in advanced medical treatments, particularly photopheresis systems and solutions for the treatment of Cutaneous T-Cell Lymphoma (CTCL). The company provides innovative immunomodulatory therapies, professional resources, and support services to healthcare professionals in the US. Their mission is to enhance immunologic response and improve patient outcomes through their specialized systems and solutions.
Industries
Nr. of Employees
Very Large (1000+)
Therakos
Patents
Systems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver no for inhalation therapy to a patient
US-12257391-B2
View DetailsMethods of reducing the risk of mortality associated with a medical treatment
US-11992620-B2
View DetailsSystems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient
US-11554242-B2
View Details
Systems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver no for inhalation therapy to a patient
US-12257391-B2
View DetailsMethods of reducing the risk of mortality associated with a medical treatment
US-11992620-B2
View DetailsSystems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient
US-11554242-B2
View DetailsProducts
Integrated extracorporeal photopheresis system
Medical device platform designed to perform extraction, centrifugal separation, leukocyte enrichment, ex vivo photosensitizer exposure, UVA photoactivation of treated blood components, and reinfusion within a closed sterile fluid path.
Sterile psoralen solution for extracorporeal administration
Sterile formulation of a psoralen (methoxsalen) photoactive compound intended for ex vivo administration to leukocyte‑enriched blood prior to ultraviolet‑A activation during extracorporeal photopheresis procedures.
Integrated extracorporeal photopheresis system
Medical device platform designed to perform extraction, centrifugal separation, leukocyte enrichment, ex vivo photosensitizer exposure, UVA photoactivation of treated blood components, and reinfusion within a closed sterile fluid path.
Sterile psoralen solution for extracorporeal administration
Sterile formulation of a psoralen (methoxsalen) photoactive compound intended for ex vivo administration to leukocyte‑enriched blood prior to ultraviolet‑A activation during extracorporeal photopheresis procedures.
Services
Online courses, personalized onsite instruction, and laboratory skills sessions to develop procedural competency for extracorporeal photopheresis operators.
Around‑the‑clock customer care for orders, inquiries, and reporting quality complaints, with professional phone support and access to product information.
Instrument installation and on‑site technical service; post‑warranty on‑site services available for an incremental charge.
Scheduling and provision of phone, virtual, or on‑site meetings with clinical educators and business managers to address clinician questions and contracting needs.
Restricted online portal providing registered operators with access to operator resources, training materials, operator manuals, and account management.
Downloadable guides and online resources summarizing billing codes and reimbursement considerations for extracorporeal photopheresis procedures (informational only).
Online courses, personalized onsite instruction, and laboratory skills sessions to develop procedural competency for extracorporeal photopheresis operators.
Around‑the‑clock customer care for orders, inquiries, and reporting quality complaints, with professional phone support and access to product information.
Instrument installation and on‑site technical service; post‑warranty on‑site services available for an incremental charge.
Scheduling and provision of phone, virtual, or on‑site meetings with clinical educators and business managers to address clinician questions and contracting needs.
Restricted online portal providing registered operators with access to operator resources, training materials, operator manuals, and account management.
Downloadable guides and online resources summarizing billing codes and reimbursement considerations for extracorporeal photopheresis procedures (informational only).
Expertise Areas
- Extracorporeal photopheresis therapy for cutaneous T‑cell lymphoma
- Clinical procedure design and operator training for extracorporeal systems
- Patient selection, treatment scheduling, and response assessment for ECP
- Pharmacovigilance and adverse event reporting for photoactivation therapies
Key Technologies
- Extracorporeal photopheresis
- Ultraviolet A (UVA) irradiation of blood components
- Psoralen (methoxsalen) photoactivation
- Centrifugation-based blood fractionation and buffy coat isolation
News & Updates
Information on reimbursement and billing support for photopheresis treatments.
Information on reimbursement and billing support for photopheresis treatments.